THER-01. Targeted therapy and intracranial metastatic disease: a population-based retrospective cohort study

BACKGROUND: Targeted therapies have been hypothesized to prolong survival in the management of patients with intracranial metastatic disease (IMD), but, paradoxically, to increase IMD incidence by improving systemic disease control and prolonging survival from the primary tumor. The real-world benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Anders, Habbous, Steven, Wright, Frances, Lofters, Aisha, Jerzak, Katarzyna, Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351316/
http://dx.doi.org/10.1093/noajnl/vdab071.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351316/
http://dx.doi.org/10.1093/noajnl/vdab071.048

Ejemplares similares